Barry FitzGerald: Looking for leverage to nuclear renaissance? Uranium play Lotus takes the yellowcake
Gold Digger: State Street sees US$5000/oz gold on the cards in 2026
Closing Bell: ASX succumbs to headwinds as Macquarie and Qantas slide
Resources Top 5: Lithium Universe taps into circular economy with silver recycling plan
Monsters of Rock: Canaccord lifts rare earths price forecasts and Trump’s critical minerals update
Scott Power: ASX health sector dips, CSL steadies, Imricor delivers jolt of good news
Frequent-flyer fanatics share their wildest status and points hacks
Lunch Wrap: ASX wobbles, Musk lands a trillion-dollar vote of faith
PLS not eyeing BMX revival, but cautious optimism returns as lithium miners spot green shoots
What’s new and hot in Thailand in 2026
Contributors
Our Resident Experts
Mining
Gold Digger: State Street sees US$5000/oz gold on the cards in 2026
Resources Top 5: Lithium Universe taps into circular economy with silver recycling plan
Monsters of Rock: Canaccord lifts rare earths price forecasts and Trump’s critical minerals update
PLS not eyeing BMX revival, but cautious optimism returns as lithium miners spot green shoots
Resources Top 5: Exploration ramps up as small caps keep foot on the gas
Featured in Mining
Tech
Unicorns Podcast: How 333D is reinventing itself through AI, healthcare and digital assets
Top cyber scientist warns of quantum computing security threats
ASX Tech October Winners: Sector buckles under Xero and WiseTech, but Weebit joins $1bn club
ASX Quarterly Tech Wrap: Acquisitions, deals and capital raises
The biometric edge: Can algorithms help you crack the three-hour marathon?
Featured in Tech
Health & Biotech
Biohacking is more popular than ever, but how healthy is the fixation on longevity?
‘Time is brain’: EMVision clocks key milestones in big year for its portable stroke-diagnostic tech
Health Check: It’s all the way in the USA as ASX medtechs ramp up in Trumpland
From Petri dishes to pharma giants, Clever Culture’s AI goes global
Health Check: Our flu recovery prognosis is positive, CSL tells investors
Featured in Health & Biotech
Experts
Insurance for cancer, heart attacks and strokes hits the sick list
Silver tsunami wave captures 700,000 retirees in super tax trap
How the cheapest ETF investment strategy is minting millionaires
Reasons why inflation is high and an interest rate cut is off the table for the RBA
Stock Tips: Energy, property and F1-fuelled momentum drive this week’s picks
Criterion: In fostering truly sustainable investments, ELM waters the flowers and not the weeds
How to follow Rinehart’s lead and play the critical minerals boom
